Sponsor Check › Issuer
Corporation · organized in Delaware · formed more than five years before filing · Janesville, WI
Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer Jun 28, 2019 · Courts (RECAP) last checked: Oct 24, 2026, 2:12 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
SHINE Medical Technologies, Inc. is a corporation organized in Delaware (formed more than five years before filing), based in Janesville, WI.
What this means A deal company is usually set up for one investment; its Form D is the notice it files after selling to investors.
It has filed 10 Form D filings (5 originals, 5 amendments) for 5 offerings between Mar 2011 and Jun 2019. The latest filing of each offering reports a combined $83.7M sold of $111.5M offered to 479 investors; industry as reported: other health care; latest exemption Rule 506(b).
What this means A repeat filer — 5 separate raises over about 8 years. Amendments are routine updates (an ongoing raise must update its Form D at least once a year).
Key people as listed: Anton Asmuth (executive officer and director), Brad Wucherpfennig (director), Gordon Gunnlaugsson (director), Gregory Richard Piefer (executive officer and director), Gregory Smith (director) and 15 more.
What this means These are the people the company itself named as running or promoting it. Tap a name to see every other deal they are on.
Reported money out: $455K in sales commissions and $256K of proceeds to officers, directors or promoters (latest filing per offering). Paid to sell it: Piper Jaffray & Co..
What this means $256K of investor money was reported as going to the people running the deal — about 0.3% of what was sold. The form does not say what for (fees, salaries, buying something from them); ask. $455K went to brokers for selling it (about 0.5% of what was sold).
Activity: 0 new offerings in the last 12 months; latest amendment Apr 3, 2017; latest filing Jun 28, 2019.
What this means No new raise filed in the past year — this deal company may be done raising, or simply quiet.
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched SHINE Medical Technologies, Inc..
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY), property records (NYC, FL, IL and TX counties) — none found.
What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for SHINE Medical Technologies, Inc. and found 15 differences, 2 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; 4 people are no longer listed on a later amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
No Secretary of State record matched in the registries searched (the issuer's reported state of incorporation, DE, has not been searched). Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
1 possible match is in human review and not shown.
Community search for SHINE Medical Technologies, Inc. has not run yet — it is joining a line of 58,317 names; searches run around the clock at the hosts' allowed rate. Searched so far: 654 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:12 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched SHINE Medical Technologies, Inc...
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:12 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No comparisons published
No public statement by this issuer has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this issuer yet.
15 differences found between the filings for SHINE Medical Technologies, Inc. — 2 worth asking about (compared 10 filings on Oct 24, 2026)
United States Bankruptcy Court, E.D. Wisconsin docket "Piefer v. Wells Fargo Bank, N.A." filed Nov 19, 2012, closed Feb 13, 2013. Gregory Richard Piefer (listed on the same filings) is listed as Plaintiff ("Piefer"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The Jun 14, 2011 Form D/A reports $2,436,083 sold and $256,310 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
The Mar 3, 2011 Form D reports $1,394,000 sold and $256,310 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
Form D filed 63 days after the first sale — SHINE Medical Technologies, Inc. · Form D filed 223 days after the first sale — SHINE Medical Technologies, Inc. · Form D filed 816 days after the first sale — SHINE Medical Technologies, Inc. · Form D filed 69 days after the first sale — SHINE Medical Technologies, Inc.
What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.
No amendment in the last 12 months on an offering that may still be open — SHINE Medical Technologies, Inc. (latest filing Jun 28, 2019) · No amendment in the last 12 months on an offering that may still be open — SHINE Medical Technologies, Inc. (latest filing Nov 29, 2018) · No amendment in the last 12 months on an offering that may still be open — SHINE Medical Technologies, Inc. (latest filing Sep 6, 2017) · No amendment in the last 12 months on an offering that may still be open — SHINE Medical Technologies, Inc. (latest filing Apr 3, 2017)
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Richard Vann Bynum is no longer listed on the Jan 13, 2017 amendment — SHINE Medical Technologies, Inc. · Todd Asmuth is no longer listed on the Jan 13, 2017 amendment — SHINE Medical Technologies, Inc. · David A. Weissburg is no longer listed on the Oct 19, 2012 amendment — SHINE Medical Technologies, Inc. · Richard Vann Bynum is no longer listed on the Jun 14, 2011 amendment — SHINE Medical Technologies, Inc.
What this means People leave; the issuer lists only current officers, directors and promoters. Ask why and who replaced them.
The Oct 19, 2012 filing lists Gregory Richard Piefer as executive officer, director, promoter; the Jan 5, 2016 Form D lists executive officer, director.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Oct 19, 2012 filing lists Richard Vann Bynum as director; the Jan 5, 2016 Form D lists executive officer.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Jun 14, 2011 filing lists Stephen Clermont Hathaway as executive officer; the Mar 20, 2012 Form D/A lists executive officer, promoter.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Jan 13, 2017 filing says $29,034,972 offered; the Apr 3, 2017 Form D/A says $30,034,972.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Jan 5, 2016 filing says $11,534,972 offered; the Jan 13, 2017 Form D/A says $29,034,972.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Mar 3, 2011 filing says $1,394,000 offered; the Jun 14, 2011 Form D/A says $11,436,083.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The people listed on the Jan 5, 2016 filing give Monona, WI; on the Jan 13, 2017 filing they give Janesville, WI.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Mar 20, 2012 filing give Middleton, WI; on the Oct 19, 2012 filing they give Monona, WI.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
SEC records list prior names for this filer: Shine Medical Technologies, Inc.. The current name on file is "SHINE Medical Technologies, Inc.".
What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
2 of 5 offerings report sales commissions totalling $455,000; 0 report finder's fees; 1 reports proceeds to related persons totalling $256,310. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Jun 28, 2019 D File 021-343116 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 29, 2018 D File 021-326835 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 6, 2017 D File 021-294097 | $155,000 | $0 | $0 | Piper Jaffray & Co. BrokerCheck CRD 665 ↗ via Piper Jaffray & Co. (CRD 665 ↗) | EDGAR ↗ |
| Apr 3, 2017 D/A File 021-254552 | $300,000 | $0 | $0 | Piper Jaffray & Co. BrokerCheck CRD 665 ↗ via Piper Jaffray & Co. (CRD 665 ↗) | EDGAR ↗ |
| Oct 19, 2012 D/A File 021-156138 | $0 | $0 | $256,310 (est.) | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
0 recorded documents and 0 ownership records matched to SHINE Medical Technologies, Inc. in the sources searched.
Not found in sources searched as of Oct 24, 2026, 10:16 AM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Harris County TX (HCAD ownership rolls 2005–2026) — 1,032,426 records, loaded Oct 24, 2026, 8:00 AM ET; Dallas County TX (DCAD ownership rolls 2021–2027) — 285,535 records, loaded Oct 24, 2026, 8:20 AM ET; Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll) — 514,336 records, loaded Oct 24, 2026, 8:25 AM ET; King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published) — 538,619 records, loaded Oct 24, 2026, 8:27 AM ET; Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026) — 1,263,035 records, loaded Oct 24, 2026, 9:34 AM ET. Still to be looked up for this issuer: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Harris County TX (ownership only, no deed, mortgage or sale records; HCAD ownership rolls 2005–2026); Dallas County TX (ownership only, no deed, mortgage or sale records; DCAD ownership rolls 2021–2027); Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll); King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published); Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026); also looked up per issuer when its page is viewed. Recorder indexes (party names on deeds, mortgages and liens) in TX, AZ, NV, CA and WA counties and outside the Clerk index in FL, mortgages and liens outside NYC and Hillsborough County, lis pendens and foreclosure notices everywhere, Los Angeles County CA, Clark County NV, New York City bulk pass (not finished; per-issuer lookups only so far), Maricopa County AZ (loader ready; commercial-purpose statement not yet filed), Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 8:30 AM ET; King County WA Assessor Real Property Sales extract (EXTR_RPSale.csv) Oct 24, 2026, 8:27 AM ET; Florida DOR NAL roll (Palm Beach 60) Oct 24, 2026, 8:25 AM ET; Florida DOR NAL roll (Broward 16) Oct 24, 2026, 8:24 AM ET; Florida DOR NAL roll (Dade 23) Oct 24, 2026, 8:23 AM ET; Florida DOR NAL roll (Hillsborough 39) Oct 24, 2026, 8:21 AM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 24, 2026, 8:20 AM ET; Harris County Appraisal District real_acct.txt Oct 24, 2026, 8:00 AM ET; Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET. NYC and Cook County are also looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|---|---|---|---|---|---|
| 021-343116 | Jun 28, 2019 EDGAR ↗ | Jun 28, 2019 D EDGAR ↗ | 0 | $30,000,000 | $18,081,000 | Other Health Care |
| 021-326835 | Nov 29, 2018 EDGAR ↗ | Nov 29, 2018 D EDGAR ↗ | 0 | $24,558,131 | $17,958,673 | Other Health Care |
| 021-294097 | Sep 6, 2017 EDGAR ↗ | Sep 6, 2017 D EDGAR ↗ | 0 | $15,500,000 | $6,881,987 | Other Health Care |
| 021-254552 | Jan 5, 2016 EDGAR ↗ | Apr 3, 2017 D/A EDGAR ↗ | 2 latest Apr 3, 2017 | $30,034,972 | $29,346,241 | Other Health Care |
| 021-156138 | Mar 3, 2011 EDGAR ↗ | Oct 19, 2012 D/A EDGAR ↗ | 3 latest Oct 19, 2012 | $11,436,083 | $11,436,083 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
| Filing | Form D filed Jun 28, 2019 SEC file no. 021-343116 · accession 0000897069-19-000327 |
|---|---|
| Raise progress | $18,081,000 sold of $30,000,000 offered (60%) · $11,919,000 remaining · first sale Apr 26, 2019 |
| Filing timing | Date of first sale: Apr 26, 2019 · Form D filed: Jun 28, 2019 (63 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 2,739 days (7.5 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 99 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Anton Asmuth, Chief Financial Officer (Jun 28, 2019) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $30,000,000. Typical range: $829,831–$9,999,998. Investors: 99. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Nov 29, 2018 SEC file no. 021-326835 · accession 0000897069-18-000621 |
|---|---|
| Raise progress | $17,958,673 sold of $24,558,131 offered (73%) · $6,599,458 remaining · first sale Apr 20, 2018 |
| Filing timing | Date of first sale: Apr 20, 2018 · Form D filed: Nov 29, 2018 (223 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,110 days (8.5 years) |
| Annual amendments | Issuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 122 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Anton Asmuth, Chief Financial Officer (Nov 29, 2018) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $24,558,131. Typical range: $829,831–$9,999,998. Investors: 122. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Sep 6, 2017 SEC file no. 021-294097 · accession 0000897069-17-000452 |
|---|---|
| Raise progress | $6,881,987 sold of $15,500,000 offered (44%) · $8,618,013 remaining · first sale Aug 25, 2017 |
| Filing timing | Date of first sale: Aug 25, 2017 · Form D filed: Sep 6, 2017 (12 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,348 days (9.2 years) |
| Annual amendments | Issuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 26 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | Piper Jaffray & Co. — FINRA BrokerCheck CRD 665 ↗ · associated broker-dealer: Piper Jaffray & Co. (CRD 665 ↗) Solicits in: CA, CO, FL, IL, NC, NE, NY, WI |
| Money to insiders | Sales commissions: $155,000 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Darin Janecek, Chief Financial Officer (Sep 5, 2017) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $15,500,000. Typical range: $829,831–$9,999,998. Investors: 26. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D/A (amendment) filed Apr 3, 2017 · amends 0000897069-17-000022 ↗ SEC file no. 021-254552 · accession 0000897069-17-000203 · filing 3 of 3 in this offering |
|---|---|
| Raise progress | $29,346,241 sold of $30,034,972 offered (98%) · $688,731 remaining · first sale Oct 11, 2013 |
| Filing timing | Date of first sale: Oct 11, 2013 · Original Form D filed: Jan 5, 2016 (816 days after first sale) · This amendment (Form D/A) filed: Apr 3, 2017 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
| Time since first sale | 4,762 days (13.0 years) |
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Apr 3, 2017. Most recent amendment for this offering in our index: this filing, Apr 3, 2017. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 217 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | Piper Jaffray & Co. — FINRA BrokerCheck CRD 665 ↗ · associated broker-dealer: Piper Jaffray & Co. (CRD 665 ↗) Solicits in: CA, CO, FL, IL, NC, NE, NY, WI |
| Money to insiders | Sales commissions: $300,000 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Darin Janecek, Chief Financial Officer (Apr 3, 2017) |
| Changes vs previous filing |
Compared with the D/A filed Jan 13, 2017 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $30,034,972. Typical range: $829,831–$9,999,998. Investors: 217. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D/A (amendment) filed Jan 13, 2017 · amends 0000897069-16-000570 ↗ SEC file no. 021-254552 · accession 0000897069-17-000022 · filing 2 of 3 in this offering |
|---|---|
| Raise progress | $27,179,741 sold of $29,034,972 offered (94%) · $1,855,231 remaining · first sale Oct 11, 2013 |
| Filing timing | Date of first sale: Oct 11, 2013 · Original Form D filed: Jan 5, 2016 (816 days after first sale) · This amendment (Form D/A) filed: Jan 13, 2017 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
| Time since first sale | 4,762 days (13.0 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Jan 13, 2017. Most recent amendment for this offering in our index: Apr 3, 2017 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 208 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Anton Asmuth, President (Jan 13, 2017) |
| Changes vs previous filing |
Compared with the D filed Jan 5, 2016 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $29,034,972. Typical range: $829,831–$9,999,998. Investors: 208. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Jan 5, 2016 SEC file no. 021-254552 · accession 0000897069-16-000570 · filing 1 of 3 in this offering |
|---|---|
| Raise progress | $11,534,972 sold of $11,534,972 offered (100%) · $0 remaining · first sale Oct 11, 2013 |
| Filing timing | Date of first sale: Oct 11, 2013 · Form D filed: Jan 5, 2016 (816 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 4,762 days (13.0 years) |
| Annual amendments | Issuer reported the offering may last more than one year. Most recent amendment for this offering in our index: Apr 3, 2017 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 93 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Darin Janecek, Chief Financial Officer (Jan 5, 2016) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $11,534,972. Typical range: $829,831–$9,999,998. Investors: 93. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D/A (amendment) filed Oct 19, 2012 · amends 0000897069-12-000222 ↗ SEC file no. 021-156138 · accession 0000897069-12-000401 · filing 4 of 4 in this offering |
|---|---|
| Raise progress | $11,436,083 sold of $11,436,083 offered (100%) · $0 remaining · first sale Dec 24, 2010 |
| Filing timing | Date of first sale: Dec 24, 2010 · Original Form D filed: Mar 3, 2011 (69 days after first sale) · This amendment (Form D/A) filed: Oct 19, 2012 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
| Time since first sale | 5,784 days (15.8 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Oct 19, 2012. Most recent amendment for this offering in our index: this filing, Oct 19, 2012. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 15 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Debt; Other: Conversion of Debt to Equity and Sale of Additional Equity |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $256,310 (est.) |
| Signed by | Gregory R. Piefer, Chief Executive Officer (Oct 18, 2012) |
| Changes vs previous filing |
Compared with the D/A filed Mar 20, 2012 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D/A (amendment) filed Mar 20, 2012 · amends 0000897069-11-000281 ↗ SEC file no. 021-156138 · accession 0000897069-12-000222 · filing 3 of 4 in this offering |
|---|---|
| Raise progress | $5,436,083 sold of $11,436,083 offered (48%) · $6,000,000 remaining · first sale Dec 24, 2010 |
| Filing timing | Date of first sale: Dec 24, 2010 · Original Form D filed: Mar 3, 2011 (69 days after first sale) · This amendment (Form D/A) filed: Mar 20, 2012 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
| Time since first sale | 5,784 days (15.8 years) |
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Mar 20, 2012. Most recent amendment for this offering in our index: Oct 19, 2012 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 15 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Debt; Other: Conversion of Debt to Equity and Sale of Additional Equity |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $256,310 (est.) |
| Signed by | Gregory R. Piefer, Chief Executive Officer (Mar 19, 2012) |
| Changes vs previous filing |
Compared with the D/A filed Jun 14, 2011 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D/A (amendment) filed Jun 14, 2011 · amends 0000897069-11-000235 ↗ SEC file no. 021-156138 · accession 0000897069-11-000281 · filing 2 of 4 in this offering |
|---|---|
| Raise progress | $2,436,083 sold of $11,436,083 offered (21%) · $9,000,000 remaining · first sale Dec 24, 2010 |
| Filing timing | Date of first sale: Dec 24, 2010 · Original Form D filed: Mar 3, 2011 (69 days after first sale) · This amendment (Form D/A) filed: Jun 14, 2011 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
| Time since first sale | 5,784 days (15.8 years) |
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Jun 14, 2011. Most recent amendment for this offering in our index: Oct 19, 2012 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 13 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Debt; Other: Conversion of Debt to Equity and Sale of Additional Equity |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $256,310 (est.) |
| Signed by | David A. Weissburg, President (Jun 14, 2011) |
| Changes vs previous filing |
Compared with the D filed Mar 3, 2011 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Mar 3, 2011 SEC file no. 021-156138 · accession 0000897069-11-000235 · filing 1 of 4 in this offering |
|---|---|
| Raise progress | $1,394,000 sold of $1,394,000 offered (100%) · $0 remaining · first sale Dec 24, 2010 |
| Filing timing | Date of first sale: Dec 24, 2010 · Form D filed: Mar 3, 2011 (69 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 5,784 days (15.8 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Oct 19, 2012 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 12 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Debt |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $256,310 (est.) |
| Signed by | Gregory R. Piefer, Chief Executive Officer, Secretary and a Director (Mar 3, 2011) |
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Amendment filed | File no. | Compared with | What changed (both values as filed) |
|---|---|---|---|
| Apr 3, 2017 EDGAR ↗ | 021-254552 | Jan 13, 2017 D/A | total sold: $27,179,741 (Jan 13, 2017) → $29,346,241 (Apr 3, 2017) · total offering: $29,034,972 (Jan 13, 2017) → $30,034,972 (Apr 3, 2017) · remaining: $1,855,231 (Jan 13, 2017) → $688,731 (Apr 3, 2017) · and 4 more (open the filing above) |
| Jan 13, 2017 EDGAR ↗ | 021-254552 | Jan 5, 2016 D | total sold: $11,534,972 (Jan 5, 2016) → $27,179,741 (Jan 13, 2017) · total offering: $11,534,972 (Jan 5, 2016) → $29,034,972 (Jan 13, 2017) · remaining: $0 (Jan 5, 2016) → $1,855,231 (Jan 13, 2017) · and 4 more (open the filing above) |
| Oct 19, 2012 EDGAR ↗ | 021-156138 | Mar 20, 2012 D/A | total sold: $5,436,083 (Mar 20, 2012) → $11,436,083 (Oct 19, 2012) · remaining: $6,000,000 (Mar 20, 2012) → $0 (Oct 19, 2012) · may last more than one year: yes (Mar 20, 2012) → no (Oct 19, 2012) · and 2 more (open the filing above) |
| Mar 20, 2012 EDGAR ↗ | 021-156138 | Jun 14, 2011 D/A | total sold: $2,436,083 (Jun 14, 2011) → $5,436,083 (Mar 20, 2012) · remaining: $9,000,000 (Jun 14, 2011) → $6,000,000 (Mar 20, 2012) · investors: 13 (Jun 14, 2011) → 15 (Mar 20, 2012) |
| Jun 14, 2011 EDGAR ↗ | 021-156138 | Mar 3, 2011 D | total sold: $1,394,000 (Mar 3, 2011) → $2,436,083 (Jun 14, 2011) · total offering: $1,394,000 (Mar 3, 2011) → $11,436,083 (Jun 14, 2011) · remaining: $0 (Mar 3, 2011) → $9,000,000 (Jun 14, 2011) · and 4 more (open the filing above) |
Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Jun 28, 2019. Industry as reported, by offering: All 5 offerings reported: Other Health Care (2011–2019).
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|---|---|---|---|
| AA Anton Asmuth | Executive Officer, Director | WI | Jan 13, 2017 → Jun 28, 2019 on 5 of 10 filings listed on the latest filing | 1 other issuer |
| BW Brad Wucherpfennig | Director | WI | Nov 29, 2018 → Jun 28, 2019 on 2 of 10 filings listed on the latest filing | 1 other issuer |
| GG Gordon Gunnlaugsson | Director | WI | Nov 29, 2018 → Jun 28, 2019 on 2 of 10 filings listed on the latest filing | 2 other issuers |
| GP Gregory Richard Piefer | Executive Officer, Director, Promoter | WI | Mar 3, 2011 → Jun 28, 2019 on 10 of 10 filings listed on the latest filing | 3 other issuers |
| GS Gregory Smith | Director | WI | Sep 6, 2017 → Jun 28, 2019 on 3 of 10 filings listed on the latest filing | 1 other issuer |
| HS Harsh Singh | Executive Officer | WI | Jun 28, 2019 on 1 of 10 filings listed on the latest filing | — |
| KP Katrina Pitas | Executive Officer | WI | Jan 5, 2016 → Jun 28, 2019 on 4 of 10 filings listed on the latest filing | — |
| PH Philip M. Halpern | Director | NY | Jan 5, 2016 → Jun 28, 2019 on 6 of 10 filings listed on the latest filing | 1 other issuer |
| SM Steve Miltenberger | Executive Officer | WI | Nov 29, 2018 → Jun 28, 2019 on 2 of 10 filings listed on the latest filing | 1 other issuer |
| TM Thomas Rockwell Mackie | Director | WI | Mar 3, 2011 → Jun 28, 2019 on 10 of 10 filings listed on the latest filing | 7 other issuers |
| DJ Darin Janecek | Executive Officer | WI | Jan 5, 2016 → Sep 6, 2017 on 4 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
| DW Donald Whelley | Director | CT | Jun 14, 2011 → Sep 6, 2017 on 7 of 10 filings not listed on the latest filing (Jun 28, 2019) | 2 other issuers |
| RL Richard H. Leazer | Director | WI | Mar 3, 2011 → Sep 6, 2017 on 8 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
| JC James Costedio | Executive Officer | WI | Jan 5, 2016 → Apr 3, 2017 on 3 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
| RB Richard Vann Bynum separate person page: Richard Vann Bynum | Director, Executive Officer | WI | Mar 3, 2011 → Jan 5, 2016 on 5 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
| TA Todd Asmuth | Executive Officer, Director | WI | Jan 5, 2016 on 1 of 10 filings not listed on the latest filing (Jun 28, 2019) | 1 other issuer |
| CM Christopher Manuele | Director | IL | Oct 19, 2012 on 1 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
| FM Fred Mancheski | Director | FL | Jun 14, 2011 → Oct 19, 2012 on 3 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
| SH Stephen Clermont Hathaway | Executive Officer, Promoter | WI | Mar 3, 2011 → Oct 19, 2012 on 4 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
| DW David A. Weissburg | Executive Officer, Director, Promoter | WI | Mar 3, 2011 → Mar 20, 2012 on 3 of 10 filings not listed on the latest filing (Jun 28, 2019) | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (each spelling that has its own person page is linked); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (Anton M. Asmuth; Brad M. Wucherpfennig; Gordon M. Gunnlaugsson; Gregory M. Smith; Harsh M. Singh; Katrina M. Pitas; Steve M. Miltenberger; Darin Richard Janecek; Donald H. Whelley; Donald M. Whelley; James M. Costedio; Richard Clermont Vann Bynum; Richard Richard Vann Bynum; Todd M. Asmuth; Christopher H. Manuele; Fred H. Mancheski) — the filing on EDGAR is the source.
Other issuers listing the same people:
Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched SHINE Medical Technologies, Inc..
No Meta Pixel ids or Facebook / Instagram page links on file for SHINE Medical Technologies, Inc. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
No website or social profile named in SHINE Medical Technologies, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #232,420 of 374,652 in line (1,386 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for WI yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
The complete public-record profile for SHINE Medical Technologies, Inc., plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a confirmed contact for corrections. Claiming never changes the public-record section.
One-tap searches on sites we do not index ourselves, with the name pre-filled (Janesville, WI). Each opens in a new tab; what you find there is not verified by PartnerFacts.